The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer's Disease Pathology

被引:19
|
作者
Jove, Mariona [1 ]
Mota-Martorell, Natalia [1 ]
Torres, Pascual [1 ]
Ayala, Victoria [1 ]
Portero-Otin, Manuel [1 ]
Ferrer, Isidro [2 ,3 ]
Pamplona, Reinald [1 ]
机构
[1] Lleida Univ UdL, Lleida Biomed Res Inst IRBLleida, Dept Expt Med, Lleida 25198, Spain
[2] Univ Barcelona, Bellvitge Univ Hosp, Dept Pathol & Expt Therapeut, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08907, Spain
[3] ISCIII, Ctr Biomed Res Neurodegenerat Dis CIBERNED, Madrid 28220, Spain
来源
LIFE-BASEL | 2021年 / 11卷 / 05期
关键词
aging; ATP synthase; energy metabolism; entorhinal cortex; lipoxidation-derived damage; mitochondrial dysfunction; neurodegeneration; oxidative damage; MILD COGNITIVE IMPAIRMENT; MEDIAL TEMPORAL-LOBE; ANTEROLATERAL ENTORHINAL CORTEX; GENE-EXPRESSION PROFILES; HUMAN BRAIN; OXIDATIVE STRESS; LIPID-PEROXIDATION; NEURODEGENERATIVE DISEASES; PROTEOMIC IDENTIFICATION; REGIONAL VULNERABILITY;
D O I
10.3390/life11050388
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Current shreds of evidence point to the entorhinal cortex (EC) as the origin of the Alzheimer's disease (AD) pathology in the cerebrum. Compared with other cortical areas, the neurons from this brain region possess an inherent selective vulnerability derived from particular oxidative stress conditions that favor increased mitochondrial molecular damage with early bioenergetic involvement. This alteration of energy metabolism is the starting point for subsequent changes in a multitude of cell mechanisms, leading to neuronal dysfunction and, ultimately, cell death. These events are induced by changes that come with age, creating the substrate for the alteration of several neuronal pathways that will evolve toward neurodegeneration and, consequently, the development of AD pathology. In this context, the present review will focus on description of the biological mechanisms that confer vulnerability specifically to neurons of the entorhinal cortex, the changes induced by the aging process in this brain region, and the alterations at the mitochondrial level as the earliest mechanism for the development of AD pathology. Current findings allow us to propose the existence of an altered allostatic mechanism at the entorhinal cortex whose core is made up of mitochondrial oxidative stress, lipid metabolism, and energy production, and which, in a positive loop, evolves to neurodegeneration, laying the basis for the onset and progression of AD pathology.
引用
收藏
页数:21
相关论文
共 50 条
  • [11] THE ROLE OF β-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE
    Szarka Andras
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (7-8): : 222 - 228
  • [12] Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection
    Wilkins, Heather M.
    Carl, Steven M.
    Greenlief, Alison C. S.
    Festoff, Barry W.
    Swerdlow, Russell H.
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [13] Mitochondrial dysfunction in Alzheimer's disease
    D'Alessandro, Maria Clara Bila
    Kanaan, Salim
    Geller, Mauro
    Pratico, Domenico
    Daher, Joao Paulo Lima
    AGEING RESEARCH REVIEWS, 2025, 107
  • [14] MITOCHONDRIAL DYSFUNCTION IN ALZHEIMER'S DISEASE
    Kota, Lakshmi Narayanan
    Nayak, Rashmitha
    Paul, Pradip
    Viswanath, Biju
    Varghese, Mathew
    Jain, Sanjeev
    Purushottam, Meera
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S840 - S841
  • [15] SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease
    Lee, Junghee
    Kim, Yunha
    Liu, Tian
    Hwang, Yu Jin
    Hyeon, Seung Jae
    Im, Hyeonjoo
    Lee, Kyungeun
    Alvarez, Victor E.
    McKee, Ann C.
    Um, Soo-Jong
    Hur, Manwook
    Mook-Jung, Inhee
    Kowall, Neil W.
    Ryu, Hoon
    AGING CELL, 2018, 17 (01)
  • [16] Mitochondrial dysfunction and Alzheimer's disease
    Maruszak, Aleksandra
    Zekanowski, Cezary
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 320 - 330
  • [17] Mitochondrial dysfunction and Alzheimer's disease
    Ghosh, SS
    Miller, S
    Herrnstadt, C
    Fahy, E
    Shinobu, LA
    Galasko, D
    Thal, LJ
    Beal, MF
    Howell, N
    Parker, WD
    Davis, RE
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 59 - 66
  • [18] Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer’s disease with cerebrovascular disease
    Xavier Gallart-Palau
    Benjamin S. T. Lee
    Sunil S. Adav
    Jingru Qian
    Aida Serra
    Jung Eun Park
    Mitchell K. P. Lai
    Christopher P. Chen
    Raj N. Kalaria
    Siu Kwan Sze
    Molecular Brain, 9
  • [19] Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease
    Gallart-Palau, Xavier
    Lee, Benjamin S. T.
    Adav, Sunil S.
    Qian, Jingru
    Serra, Aida
    Park, Jung Eun
    Lai, Mitchell K. P.
    Chen, Christopher P.
    Kalaria, Raj N.
    Sze, Siu Kwan
    MOLECULAR BRAIN, 2016, 9
  • [20] Synaptic Mitochondrial Pathology in Alzheimer's Disease
    Du, Heng
    Guo, Lan
    Yan, Shirley ShiDu
    ANTIOXIDANTS & REDOX SIGNALING, 2012, 16 (12) : 1467 - 1475